What is Arya Health?
Arya Health operates at the intersection of artificial intelligence and healthcare administration. The company specializes in building AI-powered digital agents designed to alleviate the heavy administrative burden currently plaguing post-acute care providers. By automating complex workflows such as scheduling, compliance, and onboarding, Arya Health enables caregivers and coordinators to shift their focus from manual processes to direct patient care. Its platform is purpose-built to integrate seamlessly with leading EMRs, ensuring that healthcare organizations can maintain operational continuity while benefiting from advanced automation technology. This strategic focus on the post-acute market—a sector historically underserved by digital innovation—provides Arya Health with a significant competitive advantage in the rapidly evolving health-tech landscape.
How much funding has Arya Health raised?
Arya Health has raised a total of $40.3M across 3 funding rounds:
Angel/Seed
$4M
Stock/Share Issuance
$18.1M
Series A
$18.2M
Angel/Seed (2024): $4M with participation from Twelve Below
Stock/Share Issuance (2025): $18.1M, investors not publicly disclosed
Series A (2025): $18.2M supported by Twelve Below, Acme Capital, and Ridge Ventures
Key Investors in Arya Health
Twelve Below
Twelve Below is a New York-based firm that provides strategic capital to emerging companies, supporting early-stage growth and innovation.
Acme Capital
ACME is a San Francisco-based venture capital firm that focuses on early-stage investments in breakthrough technologies and business models that disrupt massive, traditional sectors.
Ridge Ventures
Ridge Ventures is an early-stage VC firm that partners with experienced founders to transform the software industry, emphasizing revenue growth and product-market fit through its proprietary network.
What's next for Arya Health?
With the successful closure of this major enterprise-level funding, Arya Health is expected to prioritize the expansion of its engineering and product teams to enhance its AI agent capabilities. The strategic roadmap likely includes broadening its EMR integration ecosystem and increasing market penetration across the hospice and home care segments. As the company transitions from its early-stage development phase into a period of rapid scaling, the focus will remain on achieving sustainable product-market fit and demonstrating measurable ROI for its institutional clients. Investors are closely watching how the firm utilizes this capital to solidify its market position and drive long-term value in the digital health sector.
See full Arya Health company page
